15Jan
BIVDA response to Parliament’s vote on the Brexit deal
Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.
Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”
For a copy of BIVDA's position paper on Brexit, click here.
Related
The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report ...
Read More >
BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commis...
Read More >
Doris-Ann Williams MBE, Chief Executive of BIVDA, has responded to the publication of the final repo...
Read More >
NICE has launched HealthTech Connect, an online system for identifying and supporting health technol...
Read More >
Doris-Ann Williams, Chief Executive of BIVDA, comments on the announcement of the Withdrawal Agreeme...
Read More >
Today the Secretary of State for Health and Social Care, Matt Hancock MP, has announced his vision f...
Read More >